PRSS22 and breast cancer: In our study, we examined PRSS22 mRNA expression in fresh BC tissues and nontumorous tissues, the results indicated that PRSS22 was not only significantly upregulated in BC tissues compared with breast normal tissues samples (Fig. 1B), but also expressed at higher levels in patients with LNM (Fig. 1C).